MEU:PA:PA-Lyxor UCITS MSCI Europe D-EUR (EUR)

ETF | Others |

Last Closing

USD 197.48

Change

-0.87 (-0.44)%

Market Cap

USD 0.73B

Volume

2.33K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.52 (-1.17%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

N/A

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.06 (+0.02%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.05 (-0.14%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.09 (-0.43%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.95 (+0.22%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.11 (+0.03%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.02 (-0.03%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.08 (-1.20%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.39 (+0.47%)

USD 5.54B

ETFs Containing MEU:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.01% 85% B 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.01% 85% B 75% C
Trailing 12 Months  
Capital Gain 8.41% 72% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.41% 69% C- 71% C-
Trailing 5 Years  
Capital Gain 93.40% 58% F 70% C-
Dividend Return 2.16% 3% F 3% F
Total Return 95.56% 57% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 11.94% 67% D+ 70% C-
Dividend Return 12.12% 64% D 83% B
Total Return 0.18% 18% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 11.58% 58% F 87% B+
Risk Adjusted Return 104.70% 84% B 95% A
Market Capitalization 0.73B 72% C 74% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.